A
$ Value
$0
Shares
25,000
Price
$0
Filed
Dec 23
Insider
Name
Zalevsky Jonathan
Title
Chief R&D Officer
CIK
0001789857
Roles
Officer
Transaction Details
Transaction Date
2025-12-22
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
25,000
Footnotes
Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs vest over four years from the date of grant (December 22, 2025) in substantially equal quarterly installments based on continued service. | Stock options vest over four years from the date of grant, (December 22, 2025) in substantially equal monthly installments based on continued service.
Filing Info
Zalevsky Jonathan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-18 | NKTR | ▼ | $13K |
| 2026-01-20 | NKTR | ▼ | $138K |
| 2025-12-22 | NKTR | A | $0 |
| 2025-12-22 | NKTR | A | $0 |
| 2025-11-25 | NKTR | ▼ | $63K |
| 2025-11-21 | NKTR | A | $0 |
| 2025-11-21 | NKTR | A | $0 |
| 2025-09-04 | NKTR | ▼ | $26K |
| 2025-09-04 | NKTR | ▼ | $15K |
| 2025-09-04 | NKTR | ▼ | $7K |
Other Insiders at NKTR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ROBIN HOWARD W
President & CEO
|
— | $31K | 2026-02-18 |
|
Zalevsky Jonathan
Chief R&D Officer
|
— | $13K | 2026-02-18 |